3) In accordance to the previous point, murine modeling of NF-κB signaling in CML clearly demonstrates that IKK and IκB-α are mandatory to promote BCR-ABL tumorigenesis, ruling out the controversial results obtained in cell lines. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.